Résumé
This document provides guidance to manufacturers on the minimal considerations for in vitro diagnostic (IVD) medical devices in a public health crisis: - general considerations; - risk reduction; - monitoring the devices’ post-market performance and quality assurance; - implementing a communication system. This document does not supersede the existing traditional regulatory authorization requirements for IVD medical devices available in the marketplace.
Informations générales
-
État actuel: ProjetStade: CD renvoyé au Groupe de travail [30.92]
-
Edition: 1
-
Comité technique :ISO/TC 212ICS :11.100.10
- RSS mises à jour
Cycle de vie
Vous avez une question?
Consulter notre FAQ
Service à la clientèle
+41 22 749 08 88
Horaires d’ouverture:
De lundi à vendredi - 09:00-12:00, 14:00-17:00 (UTC+1)